![](https://play.vidyard.com/BwvsVTBD3uwWXkRws6M996.jpg)
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?
Dr. Green is Clinical Professor of Dermatology, George Washington University, Washington, DC.
![](/sites/all/themes/custom/medstat_cnn/img/logo.png)
Psoriasis patients are reaching out to their dermatologists with concerns about taking biologics and the risk for coronavirus disease 2019 (COVID-19). Dr. Lawrence Green provides his recommendation, which is for patients to continue their biologics. "If you stop your biologic, and it will take a few months for your psoriasis to come back, but when that happens, if you go back to where you were you're at much more risk for COVID-19 infection than you are right now taking your biologic and controlling your disease," he reports. If patients have had exposure to COVID-19 or develop symptoms, they should stop biologics immediately. Patients taking biologics should exercise extra precautions, as recommended by the Centers for Disease Control and Prevention, to prevent infection.
![](https://play.vidyard.com/BwvsVTBD3uwWXkRws6M996.jpg)